| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/12/1995 | WO1995001447A1 Retroviral vector for the transfer and expression of genes for therapeutical purposes in eucaryotic cells |
| 01/12/1995 | WO1995001446A1 Production of trehalose in plants |
| 01/12/1995 | WO1995001445A1 Helicobacter pylori haemagglutinin/protease protein, nucleic acid encoding therefor and antibodies specific thereto |
| 01/12/1995 | WO1995001444A1 Glycolate oxidase production |
| 01/12/1995 | WO1995001443A1 Microbial transformants of hansenula that express glycolate oxidase and catalase |
| 01/12/1995 | WO1995001442A2 Nucleotide and amino acid sequences of the envelope 1 gene of 51 hepatitis c virus isolates and the use of reagents derived therefrom as diagnostic reagents and vaccines |
| 01/12/1995 | WO1995001441A1 Tuberculosis vaccine |
| 01/12/1995 | WO1995001440A1 Diagnostic skin test for tuberculosis |
| 01/12/1995 | WO1995001439A2 Plants having modified response to ethylene |
| 01/12/1995 | WO1995001438A1 Sbp members with a chemical moiety covalently bound within the binding site; production and selection thereof |
| 01/12/1995 | WO1995001437A2 Gene sequence for spinocerebellar ataxia type 1 and method for diagnosis |
| 01/12/1995 | WO1995001436A1 Conotoxins having acetylcholin receptor binding properties |
| 01/12/1995 | WO1995001435A1 A synthetic gene for d4 dopamine receptors |
| 01/12/1995 | WO1995001434A1 A truncated keratinocyte growth factor (kgf) having increased biological activity |
| 01/12/1995 | WO1995001433A1 Protein s deletion variants deficient in c4bp binding activity, but having apc cofactor activity, compositions and therapeutic methods |
| 01/12/1995 | WO1995001432A1 Novel polypeptide and dna coding for the same |
| 01/12/1995 | WO1995001431A1 Peptide family, designated as xenonins |
| 01/12/1995 | WO1995001430A1 Insect diuretic hormone receptor, preferably isolated from manduca sexta |
| 01/12/1995 | WO1995001429A1 Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases |
| 01/12/1995 | WO1995001428A1 Glycosylated and non-glycosylated bactericidal/permeability increasing proteins, and methods for producing same |
| 01/12/1995 | WO1995001427A1 Pro-urokinase mutants |
| 01/12/1995 | WO1995001424A1 Transformed mammalian cells capable of expressing cecropin b |
| 01/12/1995 | WO1995001421A1 Expression system for production of recombinant proteins in yeast |
| 01/12/1995 | WO1995001376A1 Peptide inhibitors of mitogenesis and motogenesis |
| 01/12/1995 | WO1995001370A1 Higher order structure and binding of peptide nucleic acids |
| 01/12/1995 | WO1995001369A1 Double-stranded peptide nucleic acids |
| 01/12/1995 | WO1995001365A1 Synthesis of branched nucleic acids |
| 01/12/1995 | WO1995001364A1 Chemically modified oligonucleotide for site-directed mutagenesis |
| 01/12/1995 | WO1995001363A1 Methylphosphonic acid ester, process for preparing the same and its use |
| 01/12/1995 | WO1995001359A1 Chromatographic purification and separation process for mixtures of nucleic acids |
| 01/12/1995 | WO1995001098A2 Method of controlling insects |
| 01/12/1995 | WO1995001095A1 Transformed eukaryotic cells, and transposon-based transformation vectors |
| 01/12/1995 | WO1994025595A3 Cytolysin gene and gene product |
| 01/12/1995 | WO1994018335A3 Method of controlling plant pathogenic fungi |
| 01/12/1995 | WO1994018326A3 Regulatory gene for clavulanic acid biosynthesis |
| 01/12/1995 | CA2166488A1 Glycosylated and non-glycosylated bactericidal/permeability increasing proteins, and methods for producing same |
| 01/12/1995 | CA2166462A1 Double-stranded peptide nucleic acids |
| 01/12/1995 | CA2166461A1 Higher order structure and binding of peptide nucleic acids |
| 01/12/1995 | CA2166401A1 Helicobacter pylori haemagglutinin/protease protein, nucleic acid encoding therefor and antibodies specific thereto |
| 01/12/1995 | CA2166380A1 Method for introducing a biological substance into a target |
| 01/12/1995 | CA2166298A1 Peptide family, designated as xenonins |
| 01/12/1995 | CA2166278A1 A truncated keratinocyte growth factor (kgf) having increased biological activity |
| 01/12/1995 | CA2165977A1 Pro-urokinase mutants |
| 01/12/1995 | CA2163979A1 Sbp members with a chemical moiety covalently bound within the binding site; production and selection thereof |
| 01/12/1995 | CA2163432A1 A synthetic gene for d4 dopamine receptors |
| 01/12/1995 | CA2143620A1 Retroviral vector for the transfer and expression of genes for therapeutical purposes in eucaryotic cells |
| 01/12/1995 | CA2143126A1 Process for the preparation of factor x depleted plasma |
| 01/12/1995 | CA2142713A1 Peptide inhibitors of mitogenesis and motogenesis |
| 01/11/1995 | EP0633320A1 Oligonucleotides of HCV, primers ND probes therefrom, method of determining HCV genotypes and method of detecting HVC in samples |
| 01/11/1995 | EP0633318A1 Transduced fibroblasts and uses therefor |
| 01/11/1995 | EP0633317A1 Isolated DNA sequence able to function as a termination region in chimeric genes for plant transformation |
| 01/11/1995 | EP0633316A1 Lys-aminopeptidase PepN from lactobacillus delbruckii ssp. Lactis, nucleic acids coding for it, and its use in fermentation processes |
| 01/11/1995 | EP0633315A2 Transgenic animals for the determination of agents which stimulate or repress epidermal hyperproliferation and hair growth |
| 01/11/1995 | EP0633314A1 Neurotrophin-3-deficient embryonic stem cell and its use |
| 01/11/1995 | EP0633313A1 Vaccine against lyme disease |
| 01/11/1995 | EP0633311A1 Hydrophobic amines for cellulase stabilization in liquid detergent compositions containing anionic surfactant and cellulase |
| 01/11/1995 | EP0633028A1 Vaccine against lyme disease |
| 01/11/1995 | EP0632839A1 Apparatus for containing and thermal processing of biological specimens |
| 01/11/1995 | EP0632835A1 Transgenic plants displaying multiple virus resistance and a process for their production |
| 01/11/1995 | EP0632834A1 Microorganisms having attenuated invasiveness |
| 01/11/1995 | EP0632833A1 Compositions and methods for pace 4 and 4.1 gene and polypeptides in cells |
| 01/11/1995 | EP0632832A1 Protein kinases |
| 01/11/1995 | EP0632831A1 Compositions and methods for the identification and synthesis of sialyltransferases |
| 01/11/1995 | EP0632830A1 Processes for producing ribotoxins |
| 01/11/1995 | EP0632829A1 Thrombin receptor antagonists |
| 01/11/1995 | EP0632828A1 ENDO-$g(b)-1,4-GLUCANASE AND A DNA SEQUENCE |
| 01/11/1995 | EP0632817A1 Neurotrophic factors having altered receptor binding specificities |
| 01/11/1995 | EP0632814A1 High molecular weight surface proteines of non-typeable haemophilus |
| 01/11/1995 | EP0632727A1 Conjugates formed from heat shock proteins and oligo- or polysaccharides |
| 01/11/1995 | EP0632722A1 A dna transporter system and method of use |
| 01/11/1995 | EP0598000A4 Method of diagnosing ovarian and endometrial cancer with monoclonal antibodies oxa and oxb. |
| 01/11/1995 | EP0592597A4 Novel mutagenesis methods and compositions. |
| 01/11/1995 | EP0362288B1 Expression of immunologically active proteins of human b-lymphotropic virus |
| 01/11/1995 | EP0287634B1 Positionally non-specific lipase from candida sp.; a method for producing it and its use |
| 01/11/1995 | EP0207090B1 Monoclonal antibodies and antigens for human non-small cell lung carcinomas |
| 01/11/1995 | CN1097218A Modified human granulocyte macrophagecolony stimulating factor gene and expression thereof in yeast |
| 01/10/1995 | US5380833 Polynucleotide reagents containing selectable cleavage sites |
| 01/10/1995 | US5380831 Synthetic insecticidal crystal protein gene |
| 01/10/1995 | US5380712 Truncated human serum albumin polypeptides as plasma expanding agents |
| 01/10/1995 | US5380657 DNA segments and genetic vectors |
| 01/10/1995 | US5380655 Forming transformed Haemophilus influenzae cells used to make Haemophilus P2 antigen by transforming Haemophilus host cells with recombinant vector including DNA sequence encoding the antigen; selecting transformants expressing antigen; vector |
| 01/10/1995 | US5380653 Expression vectors and methods for intracellular protein production in bascillus |
| 01/10/1995 | US5380645 Detection of nucleic acids of cancer cells, hybridizing and detection |
| 01/10/1995 | CA1333891C Purified thermostable enzyme |
| 01/07/1995 | CA2127412A1 Neurotrophin-3-deficient embryonic stem cell and its use |
| 01/07/1995 | CA2127298A1 Doubled haploids |
| 01/05/1995 | WO1995000852A2 A methodology for selecting superagonists, antagonists and superantagonists of hormones whose receptor complex includes gp 130 |
| 01/05/1995 | WO1995000851A1 Method for the diagnosis and analysis of tumours |
| 01/05/1995 | WO1995000850A1 A novel family of pollen proteinases, methods of use thereof and compositions derived therefrom |
| 01/05/1995 | WO1995000670A1 Linear and branched peptides effective in diagnosing and detecting non-a, non-b hepatitis |
| 01/05/1995 | WO1995000669A1 Parallel primer extension approach to nucleic acid sequence analysis |
| 01/05/1995 | WO1995000668A1 Method for selection of targets and nucleic acids which modulate target activity |
| 01/05/1995 | WO1995000667A1 Improved methods for detecting nucleic acid sequences |
| 01/05/1995 | WO1995000666A1 Improved nucleic acid reactions |
| 01/05/1995 | WO1995000665A1 Thermodynamics, design, and use of nucleic acid sequences |
| 01/05/1995 | WO1995000664A1 Salmonella identification by the polymerase chain reaction |
| 01/05/1995 | WO1995000663A1 Method of assaying antithrombin iii activity and reagent kit therefor |
| 01/05/1995 | WO1995000659A1 Monoclonal antibodies against the alpha pdgf receptor and uses thereof |
| 01/05/1995 | WO1995000658A1 COMPOSITIONS AND DIAGNOSTIC METHODS USING MONOCLONAL ANTIBODIES AGAINST CD44v6 |
| 01/05/1995 | WO1995000655A1 Adenovirus vectors for gene therapy |